Discontinued — last reported Q3 '25
Year-over-year, this metric grew by 34.0%, from $125.00M to $167.50M. Over 4 years (FY 2021 to FY 2025), Share Buybacks shows an upward trend with a 111.7% CAGR.
High repurchases often signal management's confidence in the company's valuation or a strategy to improve earnings per share.
The cash outflow associated with the company buying back its own shares from the open market. This is a primary method f...
Common among mature, cash-generative companies; peers in the healthcare sector often balance this with R&D investment.
share_repurchases| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.20M | $0.00 | $0.00 | $144.00M | $6.00M | $0.00 | $32.00M | $20.00M | $0.00 | $10.00M | $0.00 | $10.00M | $10.00M | $10.00M | $10.00M | $125.00M | $100.00M | $0.00 | $0.00 | $167.50M |
| QoQ Change | — | -100.0% | — | — | -95.8% | -100.0% | — | -37.5% | -100.0% | — | -100.0% | — | +0.0% | +0.0% | +0.0% | >999% | -20.0% | -100.0% | — | — |
| YoY Change | — | — | — | — | +400.0% | — | — | -86.1% | -100.0% | — | -100.0% | -50.0% | — | +0.0% | — | >999% | +900.0% | -100.0% | -100.0% | +34.0% |